PAVS earnings date and last-quarter result: last quarter miss, P/E -0.35. Updated 2026-07-23.
Paranovus Entertainment Technology (PAVS) Research Hub
Paranovus Entertainment Technology (PAVS) trades on NASDAQ, US in the Healthcare (Medical - Pharmaceuticals) sector. As of 2026-10-26, shares last closed at 2.64 USD (+3.94%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.35, market cap 0.00B. This hub links to the full technical, earnings and options research available for PAVS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Pharmaceuticals) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.64 USD (+3.94%) |
| 52-week range | 2.46 USD – 51.98 USD |
| Trend regime | Range |
| 14-day RSI | 15.4 (Oversold) |
| Trailing P/E | -0.35 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for PAVS
Covered Call on PAVS: how it works, illustrative setup around the real 2.64 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PAVS: how it works, illustrative setup around the real 2.64 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PAVS: how it works, illustrative setup around the real 2.64 USD price, max profit/loss, breakeven and when to use it. Educational.
PAVS technical analysis: range, last 2.64 USD, RSI 15.4, 52w range 2.46 USD–51.98 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PAVS in?
Paranovus Entertainment Technology (PAVS) is classified under Healthcare (Medical - Pharmaceuticals), listed on NASDAQ, US.
Is PAVS in an uptrend or downtrend?
As of 2026-10-26, PAVS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PAVS's trailing P/E ratio?
PAVS's trailing P/E is -0.35, with a market cap of 0.00B. See the earnings research page for full valuation detail.